Prudential Financial Inc. trimmed its holdings in Cantel Medical Corp. (NYSE:CMD) by 22.6% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 177,723 shares of the company’s stock after selling 51,947 shares during the quarter. Prudential Financial Inc. owned about 0.43% of Cantel Medical worth $16,736,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other large investors have also made changes to their positions in the company. Stevens Capital Management LP bought a new stake in Cantel Medical during the 3rd quarter worth approximately $580,000. Sapphire Star Partners LP bought a new position in shares of Cantel Medical in the third quarter valued at approximately $238,000. Dupont Capital Management Corp bought a new position in Cantel Medical during the third quarter valued at $709,000. Conestoga Capital Advisors LLC grew its holdings in Cantel Medical by 1.4% during the third quarter. Conestoga Capital Advisors LLC now owns 737,054 shares of the company’s stock valued at $69,408,000 after purchasing an additional 10,008 shares during the period. Finally, Crossmark Global Holdings Inc. bought a new position in Cantel Medical during the third quarter valued at $874,000. 84.98% of the stock is currently owned by institutional investors.
In other news, EVP Eric W. Nodiff sold 2,868 shares of Cantel Medical stock in a transaction that occurred on Friday, October 20th. The shares were sold at an average price of $97.55, for a total transaction of $279,773.40. Following the completion of the transaction, the executive vice president now directly owns 39,102 shares in the company, valued at $3,814,400.10. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director George L. Fotiades sold 6,000 shares of Cantel Medical stock in a transaction that occurred on Friday, October 13th. The shares were sold at an average price of $95.23, for a total transaction of $571,380.00. The disclosure for this sale can be found here. Insiders sold 36,368 shares of company stock valued at $3,576,028 over the last 90 days. 12.30% of the stock is currently owned by company insiders.
Several equities research analysts have issued reports on the company. Needham & Company LLC restated a “hold” rating on shares of Cantel Medical in a research report on Friday, September 1st. Zacks Investment Research upgraded Cantel Medical from a “sell” rating to a “hold” rating in a research report on Tuesday, August 8th. Four research analysts have rated the stock with a hold rating and one has issued a buy rating to the company. Cantel Medical has a consensus rating of “Hold” and an average price target of $91.67.
Shares of Cantel Medical Corp. (CMD) traded down $3.10 during trading hours on Monday, hitting $103.38. The stock had a trading volume of 174,127 shares, compared to its average volume of 145,759. Cantel Medical Corp. has a 52-week low of $69.21 and a 52-week high of $108.00. The company has a market capitalization of $4,320.00, a PE ratio of 51.19 and a beta of 1.24. The company has a quick ratio of 1.49, a current ratio of 2.41 and a debt-to-equity ratio of 0.24.
Cantel Medical (NYSE:CMD) last posted its earnings results on Thursday, September 28th. The company reported $0.54 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.52 by $0.02. The company had revenue of $205.50 million for the quarter, compared to analysts’ expectations of $200.32 million. Cantel Medical had a return on equity of 17.60% and a net margin of 9.27%. The firm’s revenue was up 14.8% compared to the same quarter last year. research analysts expect that Cantel Medical Corp. will post 2.34 EPS for the current fiscal year.
The firm also recently announced a Semi-Annual dividend, which will be paid on Wednesday, January 31st. Investors of record on Wednesday, January 17th will be paid a $0.085 dividend. The ex-dividend date is Tuesday, January 16th. This is a boost from Cantel Medical’s previous Semi-Annual dividend of $0.07. This represents a dividend yield of 0.17%. Cantel Medical’s dividend payout ratio (DPR) is presently 8.19%.
TRADEMARK VIOLATION WARNING: “Prudential Financial Inc. Sells 51,947 Shares of Cantel Medical Corp. (NYSE:CMD)” was first posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this piece of content on another domain, it was copied illegally and reposted in violation of United States and international trademark & copyright laws. The correct version of this piece of content can be accessed at https://www.dispatchtribunal.com/2017/12/04/prudential-financial-inc-has-16-74-million-position-in-cantel-medical-corp-cmd.html.
About Cantel Medical
Cantel Medical Corp. is a provider of infection prevention products and services in the healthcare market. The Company’s operating segments include Endoscopy; Water Purification and Filtration; Healthcare Disposables, and Dialysis. Its Endoscopy segment includes medical device reprocessing systems, disinfectants, detergents and other supplies.
Receive News & Ratings for Cantel Medical Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cantel Medical Corp. and related companies with MarketBeat.com's FREE daily email newsletter.